AcceLINX, the musculoskeletal health business accelerator launched in 2017 by OrthoWorx, has added three new consultants to assist startups in their growth from concept to commercialization: Roy Wiley (manufacturing and operations), Mark Domyhan (reimbursement) and Kris Parmelee (grant writing).
These three areas of expertise add to the services offered by AcceLINX, which was developed with the understanding that innovation in orthopaedics has become more complex, and the timeline from concept to market has extended to six or more years due to regulatory and reimbursement scrutiny. Current subject matter covered by AcceLINX includes marketing and business development; research and development; quality systems engineering and manufacturing, regulatory affairs; commercial operations and business strategy; and intellectual property and compliance.
Mr. Wiley has over 30 years of executive experience in orthopaedic product development and manufacturing. He spent the last nine years with Medtronic in a variety of manufacturing leadership roles, most recently in the position of Senior Director of Manufacturing/Site Leader. He has also held many positions in product development, including that of Director of Global Development -Extremities at Zimmer.
Mr. Domyhan has more than 20 years of experience working in reimbursement, health policy and health economics for various organizations, including orthopaedic and cardiovascular medical device companies, providers and health systems. He has held positions in the health economics and reimbursement functions at companies including Zimmer, Medtronic and St. Jude Medical.
Ms. Parmelee has been providing Federal grant proposal support services and project management to clients for over 17 years through her independent consulting firm.
In addition to these personnel moves, AcceLINK has entered into agreement with AMB Surgical whereby AcceLINX will provide consulting services to assist in the technical and regulatory development of AMB Surgical’s novel, smart automated growing rod (SAGR) for the treatment of juvenile scoliosis, traumatic injuries, etc. The technology allows for electronic control of adjustable rods used in orthopaedic procedures. Flyte SAGR allows a surgeon to perform remote, nonsurgical rod expansion. A prototype is the next key milestone for SAGR.
AMB Surgical’s Chief Executive Officer Dan Sands said in a release that the company recognizes the need for additional resources to support development and alignment with strategic commercialization partners for its SAGR technology.
Sources: AcceLINX; AMB Surgical